Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6257)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2019 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guo J, Wang M, Wang JP, Wu CX. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis via inducing cell cycle arrest and apoptosis. World J Gastroenterol 2019; 25(43): 6386-6403 [PMID: 31798276 DOI: 10.3748/wjg.v25.i43.6386] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i43/6386.htm |
| Number | Citing Articles |
| 1 |
Azmi Yerlikaya, Ertan Kanbur. The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells. Current Drug Targets 2020; 21(13): 1313 doi: 10.2174/1389450121666200525004714
|
| 2 |
Wei Huang, Hongyan Huang, Yuzhen Xiao, Lei Wang, Tingting Zhang, Xiaoling Fang, Xiaomeng Xia. UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancer. Cell Cycle 2022; 21(8): 780 doi: 10.1080/15384101.2022.2031426
|
| 3 |
Kui Cao, Xiaodong Ling, Xiangyu Jiang, Jianqun Ma, Jinhong Zhu. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. Respiratory Research 2022; 23(1) doi: 10.1186/s12931-022-02226-z
|
| 4 |
Xiangxiang Lei, Xiaoge Hu, Qiliang Lu, Wen Fu, Wen Sun, Qiancheng Ma, Dongsheng Huang, Qiuran Xu. Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers (Review). Oncology Reports 2023; 49(3) doi: 10.3892/or.2023.8500
|
| 5 |
Ruth Nousiainen, Katja Eloranta, Noora Isoaho, Stefano Cairo, David B. Wilson, Markku Heikinheimo, Marjut Pihlajoki. UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1170940
|
| 6 |
Nengqian Ma, Zhangzhan Li, Jingting Yan, Xianrong Liu, Liyan He, Ruijie Xie, Xianzhou Lu. Diverse roles of UBE2T in cancer (Review). Oncology Reports 2023; 49(4) doi: 10.3892/or.2023.8506
|
| 7 |
Mingyao Hao, Zhiqiang Dou, Luyao Xu, Zongchen Shao, Hongwei Sun, Zhaofeng Li, Zhaohui Liang. RNA Sequencing Analysis of Gene Expression by Electroacupuncture in Guinea Pig Gallstone Models. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/3793946
|
| 8 |
Nuo Xu, Yi Cui, Hong Shi, Guodong Guo, Fengyuan Sun, Tianming Jian, Huiying Rao. UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma. Investigative Opthalmology & Visual Science 2022; 63(9): 20 doi: 10.1167/iovs.63.9.20
|
| 9 |
Yucai Wu, Cuijian Zhang, Ding Peng, Shiming He, Cong Huang, Jinqin Qian, Weijie Zhu, Ninghan Feng, Yanqing Gong, Xuesong Li, Liqun Zhou. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T. Human Cell 2022; 35(2): 542 doi: 10.1007/s13577-021-00661-6
|